Key points are not available for this paper at this time.
CT-based radiomic features can be used as imaging biomarkers to predict tumor response to CRT in EC patients.
Hou et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: